The current data on the 3-month paliperidone palmitate formulation for the treatment of schizophrenia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The current data on the 3-month paliperidone palmitate formulation for the treatment of schizophrenia

Published:2018-09-22 Issue:14 Volume:19 Page:1623-1629
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Bioque Miquel¹²³^ORCID,Bernardo Miquel¹²³⁴

Affiliation:

1. Barcelona Clínic Schizophrenia Unit, Neuroscience Institute, Hospital Clínic of Barcelona, Barcelona, Spain

2. Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Barcelona, Spain

3. Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

4. University of Barcelona, Barcelona, Spain

Funder

funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2018.1515915

Reference68 articles.

1. Schizophrenia

2. Assessment of Adherence Problems in Patients with Serious and Persistent Mental Illness: Recommendations from the Expert Consensus Guidelines

3. Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

4. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

5. Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Model-Informed Clinical Development of Once-Every-6-Month Injection of Paliperidone Palmitate in Patients with Schizophrenia: A Pharmacometric Bridging Approach (Part I);European Journal of Drug Metabolism and Pharmacokinetics;2024-05-15

2. Barriers to the use of three-month Paliperidone Palmitate formulation: a study from an Italian real-world setting;Expert Review of Neurotherapeutics;2023-09-30

3. Switching to long-acting injectable antipsychotics: pharmacological considerations and practical approaches;Expert Opinion on Pharmacotherapy;2023-06-27

4. The Effect of Longer Dosing Intervals for Long-Acting Injectable Antipsychotics on Outcomes in Schizophrenia;Neuropsychiatric Disease and Treatment;2023-03

5. The Switch From Paliperidone Long-Acting Injectable 1- to 3-Monthly;Journal of Clinical Psychopharmacology;2021-11-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3